Literature DB >> 10069505

Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder.

S S Hegde1, R M Eglen.   

Abstract

Normal physiological voiding as well as generation of abnormal bladder contractions in diseased states is critically dependent on acetylcholine-induced stimulation of contractile muscarinic receptors on the smooth muscle (detrusor) of the urinary bladder. Muscarinic receptor antagonists are efficacious in treating the symptoms of bladder hyperactivity, such as urge incontinence, although the usefulness of available drugs is limited by undesirable side-effects. Detrusor smooth muscle is endowed principally with M2 and M3 muscarinic receptors with the former predominating in number. M3 muscarinic receptors, coupled to stimulation of phosphoinositide turnover, mediate the direct contractile effects of acetylcholine in the detrusor. Emerging evidence suggests that M2 muscarinic receptors, via inhibition of adenylyl cyclase, cause smooth muscle contraction indirectly by inhibiting sympathetically (beta-adrenoceptor)-mediated relaxation. In certain diseased states, M2 receptors may also contribute to direct smooth muscle contraction. Other contractile mechanisms involving M2 muscarinic receptors, such as activation of a non-specific cationic channel and inactivation of potassium channels, may also be operative in the bladder and requires further investigation. From a therapeutic standpoint, combined blockade of M2 and M3 muscarinic receptors would seem to be ideal since this approach would evoke complete inhibition of cholinergically-evoked smooth muscle contractions. However, if either the M2 or M3 receptor assumes a greater pathophysiological role in disease states, then selective antagonism of only one of the two receptors may be the more rational approach. The ultimate therapeutic strategy is also influenced by the extent to which pre-junctional M1 facilitatory and M2 inhibitory muscarinic receptors regulate acetylcholine release and also which subtypes mediate the undesirable effects of muscarinic receptor blockade such as dry mouth. Finally, the consequence of muscarinic receptor blockade in the central nervous system on the micturition reflex, an issue which is poorly studied and seldom taken into consideration, should not be ignored.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069505     DOI: 10.1016/s0024-3205(98)00581-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  44 in total

1.  Izalpinin from fruits of Alpinia oxyphylla with antagonistic activity against the rat bladder contractility.

Authors:  Yuan Yuan; Yin-Feng Tan; Peng Xu; Hailong Li; Yong-Hui Li; Wen-Ya Chen; Jun-Qing Zhang; Feng Chen; Guo-Jun Huang
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-06-04

Review 2.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 3.  Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction.

Authors:  George J Christ; Steve Hodges
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Anticholinergics and central nervous system effects: are we confused?

Authors:  David R Staskin; Edward Zoltan
Journal:  Rev Urol       Date:  2007

Review 5.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

Review 6.  Clinical pharmacokinetics and pharmacodynamics of solifenacin.

Authors:  Oxana Doroshyenko; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

7.  Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder.

Authors:  K J Pak; R S Ostrom; M Matsui; F J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

8.  Octodon degus, a new model to study the agonist and plexus-induced response in the urinary bladder.

Authors:  Francisco Eduardo Martin-Cano; Mercedes Caso-Agundez; Cristina Camello-Almaraz; Francisco Juan Santos; María Teresa Espin; Juan Antonio Madrid; Adolfo Diez-Perez; Pedro Javier Camello; Maria Jose Pozo
Journal:  J Physiol Biochem       Date:  2016-10-13       Impact factor: 4.158

9.  Muscarinic receptor expression increases following exposure to intravesical pressures of < or =40 cm-H2O: a possible mechanism for pressure-induced cell proliferation.

Authors:  Sang Don Lee; Rosalia Misseri; Cem Akbal; Chaeyong Jung; Richard C Rink; Martin Kaefer
Journal:  World J Urol       Date:  2008-06-18       Impact factor: 4.226

10.  Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity.

Authors:  F Z T Mónica; A A O Bricola; F R Báu; L L Lopes Freitas; S A Teixeira; M N Muscará; F M F Abdalla; C S Porto; G De Nucci; A Zanesco; E Antunes
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.